Serial #79231411
LIVE

Serial Number

79231411

Owner

MyMedsandMe Limited

Filing Date

Dec 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79231411 Trademark

Serial Number: 79231411 • Registration: 5635234

Serial #79231411 is a trademark filed by MyMedsandMe Limited on December 12, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MyMedsandMe Limited (4 trademarks)

2 Crossways Business Centre
Aylesbury, HP18 0RA , GB

Entity Type: 99

Trademark Details

Filing Date

December 12, 2017

Registration Date

December 25, 2018

Published for Opposition

October 9, 2018

Cancellation Date

July 11, 2025

Goods & Services

Telecommunications services, namely, transmission of data by means of telecommunications networks, wireless communication networks and the Internet; telecommunication services for providing multiple user access to a global network; transfer of data by telecommunications; transmission and reception of database information via telecommunications networks; data transmission and reception services via telecommunications means; providing telecommunications connections to databases; electronic exchange of data stored in databases accessible via telecommunication networks; communication services, namely, providing electronic transmission of information stored in a database via interactively communicating computer systems; providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; information transmission via electronic communications networks; providing multiple user access to proprietary collections of information by means of global computer information networks; telecommunications services, namely, electronic exchange of medical records between patients or health care professionals and pharmaceutical companies; telecommunication services, namely, providing access to an electronic exchange of medical records between patients or health care professionals and pharmaceutical companies

Software as a service (SAAS) services featuring software for capturing and providing data concerning quality of medication and pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; software as a service (SAAS) services featuring software for evaluating and analyzing data and information concerning the quality of medication and pharmaceuticals and the reactions and events resulting from the use of medication and pharmaceuticals; providing temporary use of on-line non-downloadable software which enables the capture of information concerning quality of medication and pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, which enables follow-up questions and answers regarding said quality, reactions and events and which enables the production of reports regarding said reactions and events; services for maintenance of computer software; providing temporary use of non-downloadable software allowing web site users to send and receive information concerning quality of medication and pharmaceuticals used, reactions and events resulting from the use of medication and pharmaceuticals, answer and read answers to follow-up questions regarding said quality, reactions and events and produce reports regarding said reactions and events; software as a service (SAAS) services featuring software for collecting, evaluating and analyzing data; design of computer software for reporting reactions and events resulting from the use of medication and pharmaceuticals; design of computer software for commercial analysis and reporting

Computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information; computer software for capturing and providing information concerning quality of medication and pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, enabling follow-up questions and answers regarding said quality, reactions and events and producing reports regarding such quality, reactions and events; computer programs for capturing and providing information concerning quality of medication and pharmaceuticals and reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said quality, reactions and events and for producing reports regarding such quality, reactions and events, computer software applications for mobile phones, smart phones, portable media players and handheld computers, namely, software for capturing information concerning quality of medication or pharmaceuticals, reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such quality, reactions and events; computer software for the evaluation and analysis of data and information concerning the quality of medication and pharmaceuticals and the reactions and events resulting from the use of medication and pharmaceuticals

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 11, 2026 INTR
CANCELLED SECTION 71
Jul 11, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 25, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 26, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 8, 2019 FICS
FINAL DISPOSITION PROCESSED
Apr 8, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 25, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 25, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 9, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 9, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Oct 6, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 19, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 19, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 19, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2018 CRFA
ASSIGNED TO LIE
Aug 21, 2018 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 31, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 31, 2018 TROA
REFUSAL PROCESSED BY IB
Jun 2, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 16, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 16, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
May 15, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 12, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 11, 2018 CNRT
ASSIGNED TO EXAMINER
May 9, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 4, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 3, 2018 REPR